Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of the COVID-19 pandemic on cardiology fellowship training in a sub-Saharan African training centre: an African perspective.

Cardiovascular journal of Africa·2023
Same author

Comparative genomics of Mortierella elongata and its bacterial endosymbiont Mycoavidus cysteinexigens.

Environmental microbiology·2017
Same author

Persistent hepatitis A infection: case report.

East African medical journal·2012
Same author

MAGIC in practice: experience of peri-operative ECF/X chemotherapy in gastro-esophageal adenocarcinomas.

Journal of surgical oncology·2012
Same author

Effectiveness of educational interventions in improving clinical competence of residents in an internal medicine residency program in Pakistan.

Education for health (Abingdon, England)·2012
Same author

Bouveret's syndrome, an unusual cause of upper gastrointestinal bleeding.

QJM : monthly journal of the Association of Physicians·2010

Related Experiment Video

Updated: Jul 7, 2026

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
06:07

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System

Published on: December 17, 2021

Osmotic demyelination syndrome: case report.

M Ngunga1, R Harania, K Hameed

  • 1Department of Medicine, Aga Khan University Hospital, P.O. Box 30270-00100, Nairobi, Kenya.

East African Medical Journal
|February 1, 2008
PubMed
Summary

A 40-year-old man diagnosed with osmotic demyelination syndrome (ODS) after hospital admission for convulsions highlights the diagnostic and management complexities of this rare neurological condition.

More Related Videos

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

Related Experiment Videos

Last Updated: Jul 7, 2026

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
06:07

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System

Published on: December 17, 2021

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

Area of Science:

  • Neurology
  • Internal Medicine

Background:

  • Osmotic demyelination syndrome (ODS) is a rare but serious neurological condition.
  • It is often associated with rapid correction of hyponatremia.
  • Early recognition and appropriate management are crucial.

Observation:

  • A 40-year-old male patient presented with convulsions.
  • The patient was admitted to the hospital for further evaluation and management.
  • Diagnostic workup led to the final diagnosis of osmotic demyelination syndrome.

Findings:

  • The case underscores the diagnostic challenges in identifying ODS.
  • Management of ODS requires careful consideration of potential complications.
  • This rare condition necessitates a multidisciplinary approach.

Implications:

  • Increased awareness of ODS among clinicians is vital.
  • Prompt diagnosis and tailored management can improve patient outcomes.
  • Further research into ODS pathophysiology and treatment is warranted.